Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats

European Journal of Pharmacology

Volumn 567, Issue 3, 2007, Pages 211-222

  Sharma, Ajaykumar N ^a,b   Chopde, Chandrabhan T ^a,b   Hirani, Khemraj ^a,d   Kokare, Dadasaheb M ^a   Ugale, Rajesh R ^b,c  

^a RTM NAGPUR UNIVERSITY   (India)

^b India   (India)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Allopregnanolone; DHEAS; Ethanol tolerance; GABAA receptor; Neurosteroids; Withdrawal anxiety

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ALCOHOL; FINASTERIDE; NEUROSTEROID; PRASTERONE SULFATE; PROGESTERONE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; GABAERGIC SYSTEM; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DEHYDROEPIANDROSTERONE SULFATE; DRUG TOLERANCE; ENZYME INHIBITORS; ETHANOL; FINASTERIDE; PREGNANOLONE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34250812474     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.04.025     Document Type: Article

References (112)

1. Allan A.M., and Harris R.A. Acute and chronic ethanol treatments alter GABA receptor-operated chloride channels. Pharmacol. Biochem. Behav. 27 (1987) 665-670
2. Alele P.E., and Devaud L.L. Differential adaptations in GABAergic and glutamatergic systems during ethanol withdrawal in male and female rats. Alcohol., Clin. Exp. Res. 29 (2005) 1027-1034
3. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., and Britton K.T. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 103 (1991) 227-232
4. Barbaccia M.L., Affricano D., Trabucchi M., Purdy R.H., Colombo G., Agabio R., and Gessa G.L. Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur. J. Pharmacol. 384 (1999) R1-R2
5. Barnard E.A., Skolnick P., Olsen R.W., Mohler H., Sieghart W., Biggio G., Braestrup C., Bateson A.N., and Langer S.Z. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50 (1998) 291-313
6. Baulieu E.E., and Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 150 (1996) S221-S239
7. Bertoglio L.J., and Carobrez A.P. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol. Biochem. Behav. 72 (2002) 449-455
8. Bicikova M., Putz Z., Hill M., Hampl R., Diebbelt L., Tallova J., and Starka L. Serum levels of neurosteroid allopregnanolone in patients with premenstrual syndrome and patients after thyroidectomy. Endocr. Regul. 32 (1998) 87-92
9. Bicikova M., Tallova J., Hill M., Krausova Z., and Hampl R. Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder. Neurochem. Res. 25 (2000) 1623-1627
10. Biggio G., Dazzi L., Biggio F., Mancuso L., Talani G., Busonero F., Mostallino M.C., Sanna E., and Follesa P. Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators. Eur. Neuropsychopharmacol. 13 (2003) 411-423
11. Birzniece V., Türkmen S., Lindblad C., Zhu D., Johansson I.M., Bäckström T., and Wahlström G. GABA(A) receptor changes in acute allopregnanolone tolerance. Eur. J. Pharmacol. 535 (2006) 125-134
12. Boyle A.E., Segal R., Smith B.R., and Amit Z. Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats. Pharmacol. Biochem. Behav. 46 (1993) 179-182
13. Brussaard A.B., and Koksma J.-J. Conditional regulation of neurosteroid sensitivity of GABAA receptors. Ann. N. Y. Acad. Sci. 1007 (2003) 29-36
14. Buck K.J., and Harris R.A. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol. J. Pharmacol. Exp. Ther. 253 (1990) 713-719
15. Cagetti E., Liang J., Spigelman I., and Olsen R.W. Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors. Mol. Pharmacol. 63 (2003) 53-64
16. Chandler L.J., Harris R.A., and Crews F.T. Ethanol tolerance and synaptic plasticity. Trends Pharmacol. Sci. 19 (1998) 491-495
17. Corpechot C., Robel P., Axelson M., Sjovall J., and Baulieu E.E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 4704-4707
18. Crippens D., White M.L., George M.A., Jaworski J.N., Brunner L.J., Lancaster F.E., and Gonzales R.A. Gender differences in blood levels, but not brain levels, of ethanol in rats. Alcohol., Clin. Exp. Res. 23 (1999) 414-420
19. Dazzi L., Serra M., Seu E., Cherchi G., Pisu M.G., Purdy R.H., and Biggio G. Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride. J. Neurochem. 83 (2002) 1103-1109
20. Devaud L.L., Smith F.D., Grayson D.R., and Morrow A.L. Chronic ethanol consumption differentially alters the expression of γ-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis. Mol. Pharmacol. 48 (1995) 861-868
21. Devaud L.L., Fritschy J.M., Sieghart W., and Morrow A.L. Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J. Neurochem. 69 (1997) 126-130
22. Dong E., Matsumoto K., Uzunova V., Sugaya I., Takahata H., Nomura H., Watanabe H., Costa E., and Guidotti A. Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2849-2854
23. Edenberg H.J., Dick D.M., Xuei X., Tian H., Almasy L., Bauer L.O., Crowe R.R., Goate A., Hesselbrock V., Jones K., Kwon J., Li T.K., Nurnberger Jr. J.I., O'Connor S.J., Reich T., Rice J., Schuckit M.A., Porjesz B., Foroud T., and Begleiter H. Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am. J. Hum. Genet. 74 (2004) 705-714
24. Eravci M., Schulz O., Grospietsch T., Pinna G., Brodel O., Meinhold H., and Baumgartner A. Gene expression of receptors and enzymes involved in GABAergic and glutamatergic neurotransmission in the CNS of rats behaviourally dependent on ethanol. Br. J. Pharmacol. 131 (2000) 423-432
25. Faingold C.L., N'Gouemo P., and Riaz A. Ethanol and neurotransmitter interactions-from molecular to integrative effects. Prog. Neurobiol. 55 (1998) 509-535
26. Finn D.A., Long S.L., Tanchuck M.A., and Crabbe J.C. Interaction of chronic ethanol exposure and finasteride: sex and strain differences. Pharmacol. Biochem. Behav. 78 (2004) 435-443
27. Follesa P., Concas A., Porcu P., Sanna E., Serra M., Mostallino M.C., Purdy R.H., and Biggio G. Role of allopregnanolone in regulation of GABA(A) receptor plasticity during long-term exposure to and withdrawal from progesterone. Brain Res. Rev. 37 (2001) 81-90
28. Follesa P., Porcu P., Sogliano C., Cinus M., Biggio F., Mancuso L., Mostallino M.C., Paoletti A.M., Purdy R.H., Biggio G., and Concas A. Changes in GABAA receptor gamma2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42 (2002) 325-336
29. Follesa P., Mancuso L., Biggio F., Mostallino M.C., Manca A., Mascia M.P., Busonero F., Talani G., Sanna E., and Biggio G. Gamma-hydroxybutyric acid and diazepam antagonize a rapid increase in GABA(A) recptors alpha(4) subunit mRNA abundence induced by ethanol withdrawal in cerebellar granule cells. Mol. Pharmacol. 63 (2003) 896-907
30. Follesa P., Biggio F., Mancuso L., Cabras S., Caria S., Gorini G., Manca A., Orru A., and Biggio G. Ethanol withdrawal-induced up-regulation of the alpha2 subunit of the GABAA receptor and its prevention by diazepam or gamma-hydroxybutyric acid. Mol. Brain Res. 120 (2004) 130-137
31. Follesa P., Biggio F., Talani G., Murru L., Serra M., Sanna E., and Biggio G. Neurosteroids, GABAA receptors, and ethanol dependence. Psychopharmacology 186 (2006) 267-280
32. Gorin R.E., Crabbe J.C., Tanchuck M.A., Long S.L., and Finn D.A. Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines. Alcohol., Clin. Exp. Res. 29 (2005) 939-948
33. Grobin A.C., Matthews D.B., Devaud L.L., and Morrow A.L. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology 139 (1998) 2-19
34. Grobin A.C., Papadeas S.T., and Morrow A.L. Regional variations in the effects of chronic ethanol administration on GABA(A) receptor expression: potential mechanisms. Neurochem. Int. 37 (2000) 453-461
35. Guidotti A., Dong E., Matsumoto K., Pinna G., Rasmusson A.M., and Costa E. The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5α-dihydroprogesterone in psychiatric disorders. Brain Res. Rev. 37 (2001) 110-115
36. Gulinello M., Gong Q.H., Li X., and Smith S.S. Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res. 910 (2001) 55-66
37. Gulinello M., Gong Q.H., and Smith S.S. Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats. Neuropharmacology 43 (2002) 701-714
38. Harris R.A., McQuilkin S.J., Paylor R., Abeliovich A., Tonegawa S., and Wehner J.M. Mutant mice lacking the gamma isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of gamma-aminobutyrate type A receptors. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3658-3662
39. Henniger M.S., Spanagel R., Wigger A., Landgraf R., and Holter S.M. Alcohol self-administration in two rat lines selectively bred for extremes in anxiety-related behavior. Neuropsychopharmacology 26 (2002) 729-736
40. Herbison A.E. Physiological roles for the neurosteroid allopregnanolone in the modulation of brain function during pregnancy and parturition. Prog. Brain Res. 133 (2001) 39-47
41. Hirani K., Khisti R.T., and Chopde C.T. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one. Neuropharmacology 43 (2002) 1339-1350
42. Hirani K., Sharma A.N., Jain N.S., Ugale R.R., and Chopde C.T. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5 alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology 180 (2005) 267-278
43. Hodge C.W., Mehmert K.K., Kelley S.P., McMahon T., Haywood A., Olive M.F., Wang D., Sanchez-Perez A.M., and Messing R.O. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nat. Neurosci. 2 (1999) 997-1002
44. Hodge C.W., Raber J., McMahon T., Walter H., Sanchez-Perez A.M., Olive M.F., Mehmert K., Morrow A.L., and Messing R.O. Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J. Clin. Invest. 110 (2002) 1003-1010
45. Holt R.A., Bateson A.N., and Martin I.L. Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex. Neuropharmacology 35 (1996) 1457-1463
46. Janak P.H., Redfern J.E., and Samson H.H. The reinforcing effects of ethanol are altered by the endogenous neurosteroid, allopregnanolone. Alcohol., Clin. Exp. Res. 22 (1998) 1106-1112
47. Janis G.C., Devaud L.L., Mitsuyama H., and Morrow A.L. Effects of chronic ethanol consumption and withdrawal on the neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one in male and female rats. Alcohol., Clin. Exp. Res. 22 (1998) 2055-2061
48. Jung M.E., Wallis C.J., Gatch M.B., and Lal H. Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal. Alcohol 21 (2000) 161-168
49. Khisti R.T., and Chopde C.T. Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice. Brain Res. 856 (2000) 291-300
50. Khisti R.T., Chopde C.T., and Jain S.P. Antidepressant-like effect of neurosteroid 3alpha-hydroxy-5 alpha-pregnan-20-one in mice forced swim test. Pharmacol. Biochem. Behav. 67 (2000) 137-143
51. Khisti R.T., Penland S.N., VanDoren M.J., Grobin A.C., and Morrow A.L. GABAergic neurosteroid modulation of ethanol actions. World J. Biol. Psychiatry 3 (2002) 87-95
52. Khisti R.T., VanDoren M.J., O'Buckley T., and Morrow A.L. Neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats. Brain Res. 980 (2003) 255-265
53. King A.R., and Hunter P.J. Alcohol elimination at low blood concentrations among women taking combined oral contraceptives. J. Stud. Alcohol 66 (2005) 738-744
54. Kokare D.M., Chopde C.T., and Subhedar N.K. Participation of alpha-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats. Neuropharmacology 51 (2006) 336-345
55. Koksma J.-J., Kesteren R.E., Rosahl T.W., Zwart R., Smit A.B., Luddens H., and Brussaard A.B. Oxytocin regulates neurosteroid modulation of GABA(A) receptors in supraoptic nucleus around parturition. J. Neurosci. 23 (2003) 788-797
56. Koob G.F. Neurobiology of addiction. Toward the development of new therapies. Ann. N. Y. Acad. Sci. 909 (2000) 170-185
57. Krystal J.H., Petrakis I.L., Krupitsky E., Schutz C., Trevisan L., and D'Souza D.C. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Anal. N. Y. Acad. Sci. 1003 (2003) 176-184
58. Kumar S., Sieghart W., and Morrow A.L. Association of protein kinase C with GABA(A) receptors containing alpha1 and alpha4 subunits in the cerebral cortex: selective effects of chronic ethanol consumption. J. Neurochem. 82 (2002) 110-117
59. Kumari M., and Ticku M.K. Regulation of NMDA receptors by ethanol. Prog. Drug Res. 54 (2000) 152-189
60. Lal H., Harris C.M., Benjamin D., Springfield A.C., Bhadra S., and Emmett-Oglesby M.W. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. J. Pharmacol. Exp. Ther. 247 (1988) 508-518
61. Lambert J.J., Belelli D., Hill-Venning C., and Peters J.A. Neurosteroids and GABAA receptor function. Trends Pharmacol. Sci. 16 (1995) 295-303
62. Langen B., and Fink H. Anxiety as a predictor of alcohol preference in rats?. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 961-968
63. Mahmoudi M., Kang M.H., Tillakaratne N., Tobin A.J., and Olsen R.W. Chronic intermittent ethanol treatment in rats increases GABA(A) receptor alpha4-subunit expression: possible relevance to alcohol dependence. J. Neurochem. 68 (1997) 2485-2492
64. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38 (1992) 379-395
65. Majewska M.D., Demirgoren S., Spivak C., and London E. The neurosteroid dehydroepiandrosterone sulfate is an antagonist of the GABAA receptor. Brain Res. 526 (1990) 143-146
66. Marutha Ravindran C.R., and Ticku M.K. Tyrosine kinase phosphorylation of GABAA receptor subunits following chronic ethanol exposure of cultured cortical neurons of mice. Brain Res. 1086 (2006) 35-41
67. Matsumoto K., Uzunova V., Pinna G., Taki K., Uzunov D.P., Watanabe H., Mienville J.M., Guidotti A., and Costa E. Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss. Neuropharmacology 38 (1999) 955-963
68. Melchior C.L., and Ritzmann R.F. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol. Biochem. Behav. 47 (1994) 437-441
69. Mhatre M.C., Pena G., Sieghart W., and Ticku M.K. Antibodies specific for GABAA receptor alpha subunits reveal that chronic alcohol treatment down-regulates alpha-subunit expression in rat brain regions. J. Neurochem. 61 (1993) 1620-1625
70. Miller S.S., Goldman M.E., Erickson C.K., and Shorey R.L. Induction of physical dependence on and tolerance to ethanol in rats fed a new nutritionally complete and balanced liquid diet. Psychopharmacology 68 (1980) 55-59
71. Morrow A.L. Regulation of GABAA receptor function and gene expression in the central nervous system. Int. Rev. Neurobiol. 38 (1995) 1-41
72. Morrow A.L., Suzdak P.D., and Paul S.M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur. J. Pharmacol. 142 (1987) 483-485
73. - uptake in cerebral cortical synaptoneurosomes. J. Pharmacol. Exp. Ther. 246 (1988) 158-164
74. Morrow A.L., Montpied P., Lingford-Huges A., and Paul S.M. Chronic ethanol and pentobarbital administration in the rat: effects on GABA(A) receptor function and expression in brain. Alcohol 7 (1990) 237-244
75. A receptor α1 and α6 subunit mRNA levels in rat cerebellum. J. Mol. Cell. Neurosci. 3 (1992) 251-258
76. Morrow A.L., VanDoren M.J., and Devaud L.L. Effects of progesterone or neuroactive steroid?. Nature 395 (1998) 652-653
77. Morrow A.L., Janis G.C., VanDoren M.J., Matthews D.B., Samson H.H., Janak P.H., and Grant K.A. Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of ethanol action?. Alcohol., Clin. Exp. Res. 23 (1999) 1933-1940
78. Morrow A.L., VanDoren M.J., Penland S.N., and Matthews D.B. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res. Rev. 37 (2001) 98-109
79. Mumenthaler M.S., Taylor J.L., O'Hara R., Fisch H.U., and Yesavage J.A. Effects of menstrual cycle and female sex steroids on ethanol pharmacokinetics. Alcohol., Clin. Exp. Res. 23 (1999) 250-255
80. Nie H., and Janak P.H. Comparison of reinstatement of ethanol-and dextrose-seeking by conditioned stimuli and priming injections of allopregnanolone after extinction in rats. Psychopharmacology 168 (2003) 222-228
81. O'Dell L.E., Alomary A.A., Vallee M., Koob G.F., Fitzgerald R.L., and Purdy R.H. Ethanol-induced increases in neuroactive steroids in the rat brain and plasma are absent in adrenalectomized and gonadectomized rats. Eur. J. Pharmacol. 484 (2004) 241-247
82. Ollat H., Parvez H., and Parvez S. Alcohol and central neurotransmission. Neurochem. Int. 13 (1988) 275-300
83. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
84. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985) 149-167
85. Petrie J., Sapp D.W., Tyndale R.F., Park M.K., Fanselow M., and Olsen R.W. Altered gaba receptor subunit and splice variant expression in rats treated with chronic intermittent ethanol. Alcohol., Clin. Exp. Res. 25 (2001) 819-828
86. Petry N.M. Benzodiazepine-GABA modulation of concurrent ethanol and dextrose reinforcement in the rat. Exp. Clin. Psychopharmacol. 5 (1997) 183-194
87. Pinna G., Uzunova V., Matsumoto K., Puia G., Mienville J.M., Costa E., and Guidotti A. Brain allopregnanolone regulates the potency of the GABA(A) receptor agonist muscimol. Neuropharmacology 39 (2000) 440-448
88. Pohorecky L.A., and Brick J. Pharmacology of ethanol. Pharmacol. Ther. 36 (1988) 335-427
89. Prasad V.V., Vegesna S.R., Welch M., and Lieberman S. Precursors of neurosteroids. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3220-3223
90. Randall R.D., Lee S.Y., Meyer J.H., Wittenberg G.F., and Gruol D.L. Acute alcohol blocks neurosteroid modulation of synaptic transmission and long-term potentiation in the rat hippocampal slice. Brain Res. 701 (1995) 238-248
91. Reddy D.S. Pharmacology of endogenous neuroactive steroids. Crit. Rev. Neurobiol. 15 (2003) 197-234
92. Reddy D.S., and Rogawski M.A. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 42 (2001) 337-344
93. Ren X., Noda Y., Mamiya T., Nagai T., and Nabeshima T. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Behav. Brain Res. 152 (2004) 243-250
94. Robinson D.L., Brunner L.J., and Gonzales R.A. Effect of gender and estrous cycle on the pharmacokinetics of ethanol in the rat brain. Alcohol., Clin. Exp. Res. 26 (2002) 165-172
95. Rossetti Z.L., and Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur. J. Pharmacol. 283 (1995) 177-183
96. Rupprecht R., Reul J.M., Trapp T., van Steensel B., Wetzel C., Damm K., Zieglgansberger W., and Holsboer F. Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11 (1993) 523-530
97. Samson H.H., and Harris R.A. Neurobiology of alcohol abuse. Trends Pharmacol. Sci. 13 (1992) 206-211
98. Sanna E., Serra M., Cossu A., Colombo G., Follesa P., Cuccheddu T., Concas A., and Biggio G. Chronic ethanol intoxication induces differential effects on GABAA and NMDA receptor function in the rat brain. Alcohol., Clin. Exp. Res. 17 (1993) 115-123
99. Sanna E., Mostallino M.C., Busonero F., Talani G., Tranquilli S., Mameli M., Spiga S., Follesa P., and Biggio G. Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal. J. Neurosci. 23 (2003) 11711-11724
100. Sanna E., Talani G., Busonero F., Pisu M.G., Purdy R.H., Serra M., and Biggio G. Brain steroidogenesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus. J. Neurosci. 24 (2004) 6521-6530
101. Sinnott R.S., Phillips T.J., and Finn D.A. Alteration of voluntary ethanol and saccharin consumption by the neurosteroid allopregnanolone in mice. Psychopharmacology 162 (2002) 438-447
102. Smith S.S., and Gong Q.H. Ethanol administration rapidly reverses alpha4 GABAA receptor subunit upregulation following steroid exposure. Neuropharmacology 47 (2004) 9-16
103. Smith B.R., Robidoux J., and Amit Z. GABAergic involvement in the acquisition of voluntary ethanol intake in laboratory rats. Alcohol 27 (1992) 227-231
104. Smith S.S., Gong Q.H., Hsu F.C., Markowitz R.S., ffrench-Mullen J.M., and Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392 (1998) 926-930
105. Smith S.S., Gong Q.H., Li X., Moran M.H., Bitran D., Frye C.A., and Hsu F.C. Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety. J. Neurosci. 18 (1998) 5275-5284
106. Suzdak P.D., Schwartz R.D., Skolnick P., and Paul S.M. Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 4071-4075
107. Ticku M.K., and Burch T. Alterations in gamma-aminobutyric acid receptor sensitivity following acute and chronic ethanol treatments. J. Neurochem. 34 (1980) 417-423
108. Tabakoff B., and Hoffman P.L. Alcohol addiction: an enigma among us. Neuron 16 (1996) 909-912
109. VanDoren M.J., Matthews D.B., Janis G.C., Grobin A.C., Devaud L.L., and Morrow A.L. Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J. Neurosci. 20 (2000) 1982-1989
110. Vanover K.E., Suruki M., Robledo S., Huber M., Wieland S., Lan N.C., Gee K.W., Wood P.L., and Carter R.B. Positive allosteric modulators of the GABA(A) receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol. Psychopharmacology 141 (1999) 77-82
111. Yu R., and Ticku M.K. Chronic neurosteroid treatment decreases the efficacy of benzodiazepine ligands and neurosteroids at the gamma-aminobutyric acidA receptor complex in mammalian cortical neurons. J. Pharmacol. Exp. Ther. 275 (1995) 784-789
112. Zimmerberg B., and Blaskey L.G. Prenatal stress effects are partially ameliorated by prenatal administration of the neurosteroid allopregnanolone. Pharmacol. Biochem. Behav. 59 (1998) 819-827